BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 3790627)

  • 21. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M; Schweiger U; Gotthardt U; Weber B; Körner A; Schmider J; Standhardt H; Lammers CH; Krumm B; Heuser I
    Biol Psychiatry; 1998 May; 43(10):762-6. PubMed ID: 9606531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
    Pfohl B; Sherman B; Schlechte J; Stone R
    Arch Gen Psychiatry; 1985 Sep; 42(9):897-903. PubMed ID: 2994590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma cortisol and 11-deoxycortisol activity in depressed patients and normal volunteers.
    Schweitzer I; Tuckwell VM; Maguire KP; Tiller JW; Harrison LC; Davies BM
    Psychoneuroendocrinology; 1991; 16(5):375-82. PubMed ID: 1805291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity.
    Lemus CZ; Asnis GM; Halbreich U; Harkavy Friedman JM; Van Praag HM; Rubinson E; Eisenberg J
    J Affect Disord; 1987; 12(3):219-21. PubMed ID: 2956306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid regulation of hypothalamic-pituitary-adrenal function in depression.
    Zis AP; Haskett RF; Albala AA; Carroll BJ; Lohr NE
    Arch Gen Psychiatry; 1985 Apr; 42(4):383-6. PubMed ID: 3977556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dexamethasone suppression test in depressed retarded adults: preliminary findings.
    Beckwith BE; Parker L; Pawlarczyk D; Couk DI; Schumacher KS; Yearwood K
    Biol Psychiatry; 1985 Aug; 20(8):825-31. PubMed ID: 4027299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology of HPA axis abnormalities in patients with major depression: an update.
    Kathol RG; Jaeckle RS; Lopez JF; Meller WH
    Am J Psychiatry; 1989 Mar; 146(3):311-7. PubMed ID: 2645793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenocorticotropin and cortisol response to lysine vasopressin in relation to the outcome of the dexamethasone suppression test in major depressive disorder.
    Akner G; Ljunggren JG; Kjellman BF; Undén F; Wetterberg L
    Acta Psychiatr Scand; 1988 Apr; 77(4):404-10. PubMed ID: 2839010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metyrapone test in depressed males.
    Morphy MA; Fava GA; Perini GI; Molnar G
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(2):187-91. PubMed ID: 4001433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulation of hypothalamic-pituitary-adrenal axis function in depressed alcoholic patients.
    Targum SD; Wheadon DE; Chastek CT; McCabe WJ; Advani MT
    J Affect Disord; 1982 Dec; 4(4):347-53. PubMed ID: 6219148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. beta-Endorphin/beta-lipotropin immunoreactivity in endogenous depression. Effect of dexamethasone.
    Matthews J; Akil H; Greden J; Charney D; Weinberg V; Rosenbaum A; Watson SJ
    Arch Gen Psychiatry; 1986 Apr; 43(4):374-81. PubMed ID: 2937385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reported weight loss and dexamethasone nonsuppression in depressed patients. A negative study.
    Gwirtsman HE; Roy-Byrne P; Gitlin MJ; Halaris A; Ahles S
    J Affect Disord; 1985 Sep; 9(2):193-6. PubMed ID: 2932495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypothalamic-pituitary-adrenal axis function and platelet serotonin concentrations in depressed patients.
    Pivac N; Jakovljević M; Mück-Seler D; Brzović Z
    Psychiatry Res; 1997 Dec; 73(3):123-32. PubMed ID: 9481804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cortisol escape from suppression by dexamethasone during depression is strongly predicted by basal cortisol hypersecretion and increasing age combined.
    Maes M; Minner B; Suy E; D'Hondt P; Jacobs MP; Raus J
    Psychoneuroendocrinology; 1991; 16(4):295-310. PubMed ID: 1745698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DST in bulimia without endogenous depression.
    Levy AB; Dixon KN
    Biol Psychiatry; 1987 Jun; 22(6):783-6. PubMed ID: 3593818
    [No Abstract]   [Full Text] [Related]  

  • 37. Abnormal pituitary function during melancholia: reduced alpha-melanocyte-stimulating hormone secretion and increased intact ACTH non-suppression.
    Maes M; DeJonckheere C; Vandervorst C; Schotte C; Cosyns P; Raus J; Suy E
    J Affect Disord; 1991 Jul; 22(3):149-57. PubMed ID: 1655852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced adrenal sensitivity to exogenous cosyntropin (ACTH alpha 1-24) stimulation in major depression. Relationship to dexamethasone suppression test results.
    Jaeckle RS; Kathol RG; Lopez JF; Meller WH; Krummel SJ
    Arch Gen Psychiatry; 1987 Mar; 44(3):233-40. PubMed ID: 3030218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. REM latency and DST results.
    Mendlewicz J
    Am J Psychiatry; 1984 Mar; 141(3):473-4. PubMed ID: 6703125
    [No Abstract]   [Full Text] [Related]  

  • 40. Memory disturbances and dexamethasone suppression test in major depression.
    Wauthy J; Ansseau M; von Frenckell R; Mormont C; Legros JJ
    Biol Psychiatry; 1991 Oct; 30(7):736-8. PubMed ID: 1958771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.